Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 14;11(4):00865-2024.
doi: 10.1183/23120541.00865-2024. eCollection 2025 Jul.

Clinical significance of respiratory bacteria and mycobacteria isolates in adult bronchiectasis in Taiwan

Affiliations

Clinical significance of respiratory bacteria and mycobacteria isolates in adult bronchiectasis in Taiwan

Chia-Ling Chang et al. ERJ Open Res. .

Abstract

Background: The clinical impact of bacterial and mycobacterial isolates on bronchiectasis remains uncertain.

Methods: Patients with bronchiectasis at 16 hospitals in Taiwan were recruited with a 1-year follow-up. The patients were classified into six groups: Group 1, Pseudomonas aeruginosa; Group 2, Klebsiella pneumoniae; Group 3, other bacteria; Group 4, non-tuberculous mycobacteria (NTM); Group 5, daily sputum without bacterial or NTM colonisation; and Group 6, dry bronchiectasis.

Results: In total, 1416 patients (mean age 67 years; 43% males) were included. The mean modified Reiff score was 5 (range 1-18). 59% (829 patients) had sputum, whereas the remaining did not. The proportions of bacteria and NTM cultured from sputum within 1 year of observation were 27% (381/1416) and 15% (202/1416), respectively. The most common bacterial isolate was P. aeruginosa (13%), followed by K. pneumoniae (7%). 26% of the patients experienced severe exacerbations at least once within the year. The 1-year all-cause mortality rate was 3%. Patients with sputum exhibited a higher rate of severe exacerbations compared to patients with dry bronchiectasis, regardless of the presence of bacteria or NTM (p<0.001). Patients with bacterial colonisation had a higher mortality rate (p<0.001). Further, the highest mortality rate was observed among those with K. pneumoniae colonisation (hazard ratio (HR) 8.39 (95% CI 2.39-29.49)), followed by individuals colonised with other bacteria (HR 8.04 (95% CI 2.36-27.38)) and P. aeruginosa (HR 7.83 (95% CI 2.45-25.03)). Additionally, old age was an independent risk factor (HR 2.72 (95% CI 1.19-6.18)).

Conclusion: K. pneumoniae was more frequently isolated from patients with bronchiectasis in Taiwan compared to Western countries and was associated with unfavourable clinical outcomes.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare no competing interests.

Figures

FIGURE 1
FIGURE 1
Microbiology in bronchiectasis. NTM: non-tuberculous mycobacteria.
FIGURE 2
FIGURE 2
Severe exacerbation of patients with bronchiectasis. Bonferroni-adjusted p-value <0.008. NTM: non-tuberculous mycobacteria.
FIGURE 3
FIGURE 3
Survival analysis of patients with bronchiectasis. NTM: non-tuberculous mycobacteria.

References

    1. Polverino E, Goeminne PC, McDonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J 2017; 50: 1700629. doi: 10.1183/13993003.00629-2017 - DOI - PubMed
    1. Diel R, Chalmers JD, Rabe KF, et al. Economic burden of bronchiectasis in Germany. Eur Respir J 2019; 53: 1802033. doi: 10.1183/13993003.02033-2018 - DOI - PubMed
    1. Dhar R, Singh S, Talwar D, et al. Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry. Lancet Glob Health 2019; 7: e1269–e1279. doi: 10.1016/S2214-109X(19)30327-4 - DOI - PubMed
    1. Dhar R, Singh S, Talwar D, et al. Clinical outcomes of bronchiectasis in India: data from the EMBARC/Respiratory Research Network of India registry. Eur Respir J 2023; 61: 2200611. doi: 10.1183/13993003.00611-2022 - DOI - PMC - PubMed
    1. Aksamit TR, O'Donnell AE, Barker A, et al. Adult patients with bronchiectasis: a first look at the US Bronchiectasis Research Registry. Chest 2017; 151: 982–992. doi: 10.1016/j.chest.2016.10.055 - DOI - PMC - PubMed

LinkOut - more resources